APA Citation

Mendoza-Posada, D., Vela-Chavez, T., Bargallo-Rocha, E., Villafañe, N., Gamboa-Vignole, C., & Arce, C. (2007). Adriamycin-Cyclophosphamide (AC) followed by Paclitaxel-Cisplatin (PC). A highly active neoadjuvant regimen in locally advanced breast cancer. BioMed Central.

Chicago Style Citation

Mendoza-Posada, Daniel, Teresa Vela-Chavez, Enrique Bargallo-Rocha, Nestor Villafañe, Carlos Gamboa-Vignole, and Claudia Arce. Adriamycin-Cyclophosphamide (AC) Followed By Paclitaxel-Cisplatin (PC). A Highly Active Neoadjuvant Regimen in Locally Advanced Breast Cancer. BioMed Central, 2007.

MLA Citation

Mendoza-Posada, Daniel, et al. Adriamycin-Cyclophosphamide (AC) Followed By Paclitaxel-Cisplatin (PC). A Highly Active Neoadjuvant Regimen in Locally Advanced Breast Cancer. BioMed Central, 2007.

Warning: These citations may not always be 100% accurate.